annual CFO:
-$300.87M-$181.81M(-152.70%)Summary
- As of today (August 20, 2025), RNA annual cash flow from operations is -$300.87 million, with the most recent change of -$181.81 million (-152.70%) on December 31, 2024.
- During the last 3 years, RNA annual CFO has fallen by -$206.06 million (-217.33%).
- RNA annual CFO is now -12183.13% below its all-time high of $2.49 million, reached on December 31, 2019.
Performance
RNA Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$199.67M-$74.84M(-59.95%)Summary
- As of today (August 20, 2025), RNA quarterly cash flow from operations is -$199.67 million, with the most recent change of -$74.84 million (-59.95%) on June 1, 2025.
- Over the past year, RNA quarterly CFO has dropped by -$134.66 million (-207.16%).
- RNA quarterly CFO is now -1310.02% below its all-time high of $16.50 million, reached on December 31, 2023.
Performance
RNA quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$489.98M-$134.66M(-37.90%)Summary
- As of today (August 20, 2025), RNA TTM cash flow from operations is -$489.98 million, with the most recent change of -$134.66 million (-37.90%) on June 1, 2025.
- Over the past year, RNA TTM CFO has dropped by -$334.31 million (-214.75%).
- RNA TTM CFO is now -3758.21% below its all-time high of $13.39 million, reached on June 30, 2019.
Performance
RNA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
RNA Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -152.7% | -207.2% | -214.8% |
| 3 y3 years | -217.3% | -461.7% | -337.0% |
| 5 y5 years | -10000.0% | -2462.8% | -1796.6% |
RNA Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -217.3% | at low | -1310.0% | at low | -337.0% | at low |
| 5 y | 5-year | <-9999.0% | at low | -1310.0% | at low | -1796.6% | at low |
| alltime | all time | <-9999.0% | at low | -1310.0% | at low | -3758.2% | at low |
RNA Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$199.67M(+60.0%) | -$489.98M(+37.9%) |
| Mar 2025 | - | -$124.83M(+25.0%) | -$355.32M(+18.1%) |
| Dec 2024 | -$300.87M(+152.7%) | -$99.87M(+52.2%) | -$300.87M(+63.1%) |
| Sep 2024 | - | -$65.61M(+0.9%) | -$184.50M(+18.5%) |
| Jun 2024 | - | -$65.00M(-7.6%) | -$155.67M(+10.8%) |
| Mar 2024 | - | -$70.38M(-526.5%) | -$140.48M(+18.0%) |
| Dec 2023 | -$119.06M(-12.6%) | $16.50M(-144.9%) | -$119.06M(-31.9%) |
| Sep 2023 | - | -$36.79M(-26.1%) | -$174.75M(+2.8%) |
| Jun 2023 | - | -$49.81M(+1.7%) | -$169.92M(+9.2%) |
| Mar 2023 | - | -$48.97M(+25.0%) | -$155.66M(+14.2%) |
| Dec 2022 | -$136.27M | -$39.19M(+22.6%) | -$136.27M(+10.5%) |
| Sep 2022 | - | -$31.96M(-10.1%) | -$123.29M(+10.0%) |
| Jun 2022 | - | -$35.55M(+20.2%) | -$112.12M(+7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$29.57M(+12.8%) | -$104.71M(+10.4%) |
| Dec 2021 | -$94.81M(+155.4%) | -$26.21M(+26.1%) | -$94.81M(+16.1%) |
| Sep 2021 | - | -$20.78M(-26.1%) | -$81.67M(+16.7%) |
| Jun 2021 | - | -$28.14M(+43.0%) | -$70.00M(+41.0%) |
| Mar 2021 | - | -$19.68M(+50.5%) | -$49.66M(+33.8%) |
| Dec 2020 | -$37.12M(-1590.6%) | -$13.07M(+43.5%) | -$37.12M(+27.7%) |
| Sep 2020 | - | -$9.11M(+17.0%) | -$29.06M(+12.5%) |
| Jun 2020 | - | -$7.79M(+9.1%) | -$25.84M(+907.6%) |
| Mar 2020 | - | -$7.14M(+42.3%) | -$2.56M(-203.0%) |
| Dec 2019 | $2.49M(-125.8%) | -$5.02M(-14.7%) | $2.49M(-66.8%) |
| Sep 2019 | - | -$5.88M(-138.0%) | $7.51M(-43.9%) |
| Jun 2019 | - | $15.48M(-842.1%) | $13.39M(-742.1%) |
| Mar 2019 | - | -$2.09M | -$2.09M |
| Dec 2018 | -$9.65M | - | - |
FAQ
- What is Avidity Biosciences, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. annual CFO year-on-year change?
- What is Avidity Biosciences, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. quarterly CFO year-on-year change?
- What is Avidity Biosciences, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. TTM CFO year-on-year change?
What is Avidity Biosciences, Inc. annual cash flow from operations?
The current annual CFO of RNA is -$300.87M
What is the all time high annual CFO for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high annual cash flow from operations is $2.49M
What is Avidity Biosciences, Inc. annual CFO year-on-year change?
Over the past year, RNA annual cash flow from operations has changed by -$181.81M (-152.70%)
What is Avidity Biosciences, Inc. quarterly cash flow from operations?
The current quarterly CFO of RNA is -$199.67M
What is the all time high quarterly CFO for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high quarterly cash flow from operations is $16.50M
What is Avidity Biosciences, Inc. quarterly CFO year-on-year change?
Over the past year, RNA quarterly cash flow from operations has changed by -$134.66M (-207.16%)
What is Avidity Biosciences, Inc. TTM cash flow from operations?
The current TTM CFO of RNA is -$489.98M
What is the all time high TTM CFO for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high TTM cash flow from operations is $13.39M
What is Avidity Biosciences, Inc. TTM CFO year-on-year change?
Over the past year, RNA TTM cash flow from operations has changed by -$334.31M (-214.75%)